EUVIMEDEUVIMED entdecken
Crossref

A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging

Yaqing Ding, Zeqian Huang, Yong Luo, Huanxin Lin, Jue Wang, Zishan Zeng, Tao Zhang, Yiwei Chen, Yujun Gong, Mingxia Zhang, Chunshun Zhao

Acta Biomaterialia · 2024-10 · 187 · 316-327

DOI: 10.1016/j.actbio.2024.08.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-10. Verfasst von Yaqing Ding und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China. Hauptthemen laut MEDLINE: Copper, Ditiocarb, Prodrugs, Endopeptidases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disulfiram (DSF), an FDA-approved drug for treating alcoholism, has been verified with Cu2+-dependent anticancer activity by forming Cu(DTC)2, the complex of one of its metabolites diethyldithiocarbamate (DTC) and Cu2+. Nevertheless, the antitumor effect is limited by insufficient Cu(DTC)2 formation in suit and off-target system toxicity. Herein, we developed a fibroblast activation protein α (FAPα) activatable nanoagent (HfD-HID-Cu) for co-delivery of DTC polymeric prodrug and exogenous Cu2+ to achieve enhanced cancer-specific therapy and activatable in situ fluorescence imaging meanwhile. HfD-HID-Cu was simply constructed through the co-assembly of the DTC polymeric prodrug (HA-fap-DTC) and the copper-loaded IR808-conjugated polymer (HA-IR-DPA-Cu), which could serve as the "OFF-to-ON" switch for chemotherapy and fluorescence. With the high expression of FAPα in tumor tissues, HA-fap-DTC could be activated specifically to release DTC, while maintaining inactive in normal tissues. The liberated DTC within tumor tissues could contend for Cu2+ from HA-IR-DPA-Cu, resulting in the formation of highly cytotoxic Cu(DTC)2in situ for chemotherapy, concomitant with the fluorescence recovery of cyanine dye for tumor imaging. This work provides an effective strategy for co-delivery of DTC prodrug and Cu2+ for tumor theranostic with improved selectivity and minimal side effects. STATEMENT OF SIGNIFICANCE: DSF-based antitumor therapy is highly dependent on Cu2+. However, the non-synchronous distribution of DSF/DTC and Cu2+ in tumor tissues attenuates the antitumor efficacy. The insufficient Cu(DTC)2 formation in suit and off-target distribution greatly limit the anti-tumor application. This study provides a nanoagent for co-delivery of DTC polymeric prodrug and Cu2+ by simple co-assembly to achieve their synchronous tumor distribution. It can be selectively activated by FAPα, forming cytotoxic Cu(DTC)2in suit for tumor-specific chemotherapy and reducing the systemic toxicity. In addition to chemotherapy, the nanoagent can emit fluorescence under the sequential triggering of FAPα and released DTC for tumor imaging. Overall, this study renders a promising strategy for improved Cu(DTC)2-based antitumor therapy and imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperDitiocarbProdrugsEndopeptidasesAnimalsHumansCell Line, TumorGelatinasesMembrane ProteinsSerine EndopeptidasesMiceMice, NudeNeoplasmsMice, Inbred BALB CNanoparticlesFibroblast Activation Protein Alpha

Stichwörter der Autor:innen

Activated imagingDiethyldithiocarbamateFibroblast activation protein αPolymeric prodrugTumor-specific therapy

Substanzen

CopperDitiocarbProdrugsEndopeptidasesGelatinasesMembrane ProteinsSerine EndopeptidasesFibroblast Activation Protein Alpha

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
  • School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China. Electronic address: zhaocs@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Guangdong Provincial Natural Science Foundation

Zitieren

APA

Ding, Y., Huang, Z., Luo, Y., Lin, H., Wang, J., Zeng, Z., Zhang, T., Chen, Y., Gong, Y., Zhang, M., & Zhao, C. (2024). A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging. Acta Biomaterialia, 187, 316-327. https://doi.org/10.1016/j.actbio.2024.08.009

Vancouver

Ding Y, Huang Z, Luo Y, Lin H, Wang J, Zeng Z, et al. A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging. Acta Biomaterialia. 2024;187:316-327. doi:10.1016/j.actbio.2024.08.009

BibTeX
@article{Ding2024,
  author = {Ding, Yaqing and Huang, Zeqian and Luo, Yong and Lin, Huanxin and Wang, Jue and Zeng, Zishan and Zhang, Tao and Chen, Yiwei and Gong, Yujun and Zhang, Mingxia and Zhao, Chunshun},
  title = {A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging},
  journal = {Acta Biomaterialia},
  year = {2024},
  volume = {187},
  pages = {316--327},
  doi = {10.1016/j.actbio.2024.08.009}
}
Kostenlos starten →